A206640 Stock Overview
Offers instruments and diagnostic reagents in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Boditech Med Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩14,900.00 |
52 Week High | ₩22,150.00 |
52 Week Low | ₩13,400.00 |
Beta | -0.67 |
11 Month Change | -11.57% |
3 Month Change | -18.49% |
1 Year Change | -21.33% |
33 Year Change | -4.49% |
5 Year Change | 69.13% |
Change since IPO | -73.22% |
Recent News & Updates
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?
Sep 13Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking
Jul 12Recent updates
Does Boditech Med (KOSDAQ:206640) Have A Healthy Balance Sheet?
Sep 13Investor Optimism Abounds Boditech Med Inc. (KOSDAQ:206640) But Growth Is Lacking
Jul 12Boditech Med Inc. (KOSDAQ:206640) Shares Fly 49% But Investors Aren't Buying For Growth
Apr 16Here's Why I Think Boditech Med (KOSDAQ:206640) Might Deserve Your Attention Today
Apr 13Could The Market Be Wrong About Boditech Med Inc. (KOSDAQ:206640) Given Its Attractive Financial Prospects?
Mar 01Boditech Med (KOSDAQ:206640) Seems To Use Debt Rather Sparingly
Jan 18Here's Why I Think Boditech Med (KOSDAQ:206640) Is An Interesting Stock
Dec 28Did Business Growth Power Boditech Med's (KOSDAQ:206640) Share Price Gain of 193%?
Dec 08Boditech Med Inc. (KOSDAQ:206640) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 18Shareholder Returns
A206640 | KR Medical Equipment | KR Market | |
---|---|---|---|
7D | -10.5% | -0.8% | 0.3% |
1Y | -21.3% | 28.4% | 6.4% |
Return vs Industry: A206640 underperformed the KR Medical Equipment industry which returned 28.4% over the past year.
Return vs Market: A206640 underperformed the KR Market which returned 6.4% over the past year.
Price Volatility
A206640 volatility | |
---|---|
A206640 Average Weekly Movement | 7.8% |
Medical Equipment Industry Average Movement | 8.1% |
Market Average Movement | 6.8% |
10% most volatile stocks in KR Market | 12.0% |
10% least volatile stocks in KR Market | 3.5% |
Stable Share Price: A206640 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A206640's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1998 | 492 | n/a | www.boditech.co.kr/en |
Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges; ichroma-50, an automated immunoassay system with high-throughput; Hemochroma PLUS, a handheld device that can run tests for anemia; portable analyzers ichroma M3 and ichroma M2; and NuActor, an automated nucleic acid extraction system. It also provides compact immunoassay analyzers, including AFIAS-1, AFIAS-3, AFIAS-6, and AFIAS-10; cardiac reagents; cancer reagents; COVID-19 reagents; diagnostic reagents; reagents for hormones, infections, autoimmune, organ functions, molecular diagnostics, therapeutic drug monitoring, and other test items.
Boditech Med Inc. Fundamentals Summary
A206640 fundamental statistics | |
---|---|
Market cap | ₩327.43b |
Earnings (TTM) | ₩30.44b |
Revenue (TTM) | ₩139.13b |
10.8x
P/E Ratio2.4x
P/S RatioIs A206640 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A206640 income statement (TTM) | |
---|---|
Revenue | ₩139.13b |
Cost of Revenue | ₩54.79b |
Gross Profit | ₩84.34b |
Other Expenses | ₩53.90b |
Earnings | ₩30.44b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.39k |
Gross Margin | 60.62% |
Net Profit Margin | 21.88% |
Debt/Equity Ratio | 4.3% |
How did A206640 perform over the long term?
See historical performance and comparison